LISBON, Portugal (AP) — Researchers in the United States and Britain are sharing a 1 million-euro ($1.16 million) prize from a Portuguese scientific foundation for developing revolutionary gene therapy that has restored the sight of children.
The Lisbon, Portugal-based Champalimaud Foundation’s annual Vision Award was given Tuesday for work on the treatment of children blinded from birth by genetic disease.
The foundation says the research brought a medical revolution, paving the way for new treatment of genetic conditions.
The winners are Michael Redmond of the U.S. National Eye Institute, who conducted pioneering early research in the field, and research teams in Pennsylvania, Florida and London, which built on that work.
Most Read Nation & World Stories
- Trump said he thinks 'the people would revolt' if he were impeached
- 'Dirty deeds': Ex-Trump lawyer Cohen gets 3 years in prison
- Delta says no more support kittens, puppies on flights
- Warming in Arctic raises fears of 'rapid unraveling’ of the region
- Amazon executives grilled, jeered at New York City Council hearing